Team Blitz India
London: An innovative ‘under the skin’ anti-cancer injection capable of reducing cancer treatment duration has been introduced by the National Health Service (NHS), England. The injection takes only seven minutes to administer and will be the first-of-its- kind in the world to be rolled out to hundreds of NHS cancer patients annually.
This revolutionary jab has the potential to curtail treatment time for specific patients by a remarkable 75 per cent. The Medicines and Healthcare Products Regulatory Agency (MHRA), a UK authority, has been entrusted with safeguarding the efficacy and safety of medical products and treatments.
A present, cancer patients receive the immunotherapy drug atezolizumab through intravenous transfusion, a process that spans 30 minutes to an hour. This shift is projected to not only elevate patients’ quality of life but also confer valuable time savings for healthcare professionals, further streamlining cancer care.
However, patients who are undergoing a combined treatment of intravenous chemotherapy and atezolizumab might still necessitate traditional transfusions.
According to NHS, nearly 3,600 patients will be receiving annual atezolizumab treatment to transition to quicker subcutaneous injections.
